Evolut™ EXPAND TAVR II Pivotal Trial

Running, not enrolling · Not applicable

Conditions studied: Moderate Aortic Valve Stenosis

In brief

Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.

Key facts

Study ID
NCT05149755
Run by
Medtronic Cardiovascular
People needed
650
Starts
2022-04-27
Expected to finish
2034-12-01
Last updated by the study team
2026-05-19

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.